Zhangzhou Pientzehuang Pharmaceutical | 600436 - Operating Profit

Stock Price
165.87
Daily Change
-0.46 -0.28%
Monthly
3.47%
Yearly
-17.83%
Q1 Forecast
163.79

Zz Pientze Pharmaceu reported CNY501.33M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 432K Sep/2025
Avita Medical AUD -11.15M 1.19M Jun/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Jiangsu Hengrui CNY 1.41B 1.4B Sep/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Moderna USD -857M 597M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Sh Fosun Pharma CNY 758.38M 67.22M Sep/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Viatris USD 234.5M 49.1M Sep/2025
Wuxi Apptec CNY 4.97B 1.19B Sep/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025
Zz Pientze Pharmaceu CNY 501.33M 52.54M Sep/2025